MoonLake Immunotherapeutics — DEFA14A Filings
9 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by MoonLake Immunotherapeutics (MLTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. MoonLake Immunotherapeutics has filed 9 DEFA14A documents with the SEC since 2020. To view all SEC filings by MoonLake Immunotherapeutics, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
EFFECT
NT 10-Q
POS AM
PREM14A
PRER14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001140361-25-014925 | Apr 22, 2025 | — |
| DEFA14A | DEFA14A | 0001140361-24-021746 | Apr 24, 2024 | — |
| DEFA14A | FORM DEFA14A | 0001140361-23-020599 | Apr 26, 2023 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-22-015052 | Mar 25, 2022 | — |
| DEFA14A | SOLICITING MATERIAL UNDER 240.14A-12 | 0001213900-22-014881 | Mar 24, 2022 | — |
| DEFA14A | CURRENT REPORT | 0001213900-22-009483 | Feb 25, 2022 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-22-002466 | Jan 19, 2022 | — |
| DEFA14A | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIAL | 0001213900-21-054981 | Oct 28, 2021 | — |
| DEFA14A | CURRENT REPORT | 0001213900-21-051259 | Oct 4, 2021 | — |